Fingerprint
Dive into the research topics of 'Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically